Search Results - "Samsel, Jakob"

Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection by Dias, Joana, Fabozzi, Giulia, Fourati, Slim, Chen, Xuejun, Liu, Cuiping, Ambrozak, David R., Ransier, Amy, Laboune, Farida, Hu, Jianfei, Shi, Wei, March, Kylie, Maximova, Anna A., Schmidt, Stephen D., Samsel, Jakob, Talana, Chloe A., Ernste, Keenan, Ko, Sung Hee, Lucas, Margaret E., Radecki, Pierce E., Boswell, Kristin L., Nishimura, Yoshiaki, Todd, John-Paul, Martin, Malcolm A., Petrovas, Constantinos, Boritz, Eli A., Doria-Rose, Nicole A., Douek, Daniel C., Sékaly, Rafick-Pierre, Lifson, Jeffrey D., Asokan, Mangaiarkarasi, Gama, Lucio, Mascola, John R., Pegu, Amarendra, Koup, Richard A.

“…Anti-HIV-1 broadly neutralizing antibodies (bNAbs) have the dual potential of mediating virus neutralization and antiviral effector functions through their Fab…”
Get full text

Application of B cell immortalization for the isolation of antibodies and B cell clones from vaccine and infection settings by Boswell, Kristin L, Watkins, Timothy A, Cale, Evan M, Samsel, Jakob, Andrews, Sarah F, Ambrozak, David R, Driscoll, Jefferson I, Messina, Michael A, Narpala, Sandeep, Hopp, Christine S, Cagigi, Alberto, Casazza, Joseph P, Yamamoto, Takuya, Zhou, Tongqing, Schief, William R, Crompton, Peter D, Ledgerwood, Julie E, Connors, Mark, Gama, Lucio, Kwong, Peter D, McDermott, Adrian, Mascola, John R, Koup, Richard A

“…The isolation and characterization of neutralizing antibodies from infection and vaccine settings informs future vaccine design, and methodologies that…”
Get full text

Rhesus macaque Bcl-6/Bcl-xL B cell immortalization: Discovery of HIV-1 neutralizing antibodies from lymph node by Samsel, Jakob, Boswell, Kristin L., Watkins, Timothy, Ambrozak, David R., Mason, Rosemarie, Yamamoto, Takuya, Ko, Sungyoul, Yang, Yongping, Zhou, Tongqing, Doria-Rose, Nicole A., Foulds, Kathryn E., Roederer, Mario, Mascola, John R., Kwong, Peter D., Gama, Lucio, Koup, Richard A.

“…Many HIV-1 vaccines are designed to elicit neutralizing antibodies, and pre-clinical testing is often carried out in rhesus macaques (RMs). We have therefore…”
Get full text

Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIV AD8-EO infection by Dias, Joana, Fabozzi, Giulia, Fourati, Slim, Chen, Xuejun, Liu, Cuiping, Ambrozak, David R, Ransier, Amy, Laboune, Farida, Hu, Jianfei, Shi, Wei, March, Kylie, Maximova, Anna A, Schmidt, Stephen D, Samsel, Jakob, Talana, Chloe A, Ernste, Keenan, Ko, Sung Hee, Lucas, Margaret E, Radecki, Pierce E, Boswell, Kristin L, Nishimura, Yoshiaki, Todd, John-Paul, Martin, Malcolm A, Petrovas, Constantinos, Boritz, Eli A, Doria-Rose, Nicole A, Douek, Daniel C, Sékaly, Rafick-Pierre, Lifson, Jeffrey D, Asokan, Mangaiarkarasi, Gama, Lucio, Mascola, John R, Pegu, Amarendra, Koup, Richard A

“…Anti-HIV-1 broadly neutralizing antibodies (bNAbs) have the dual potential of mediating virus neutralization and antiviral effector functions through their Fab…”
Get full text

Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding site by Caniels, Tom G, Medina-Ramìrez, Max, Zhang, Shiyu, Kratochvil, Sven, Xian, Yuejiao, Koo, Ja-Hyun, Derking, Ronald, Samsel, Jakob, van Schooten, Jelle, Pecetta, Simone, Lamperti, Edward, Yuan, Meng, Carrasco, María Ríos, Del Moral Sánchez, Iván, Allen, Joel D, Bouhuijs, Joey H, Yasmeen, Anila, Ketas, Thomas J, Snitselaar, Jonne L, Bijl, Tom P L, Martin, Isabel Cuella, Torres, Jonathan L, Cupo, Albert, Shirreff, Lisa, Rogers, Kenneth, Mason, Rosemarie D, Roederer, Mario, Greene, Kelli M, Gao, Hongmei, Silva, Catarina Mendes, Baken, Isabel J L, Tian, Ming, Alt, Frederick W, Pulendran, Bali, Seaman, Michael S, Crispin, Max, van Gils, Marit J, Montefiori, David C, McDermott, Adrian B, Villinger, François J, Koup, Richard A, Moore, John P, Klasse, Per Johan, Ozorowski, Gabriel, Batista, Facundo D, Wilson, Ian A, Ward, Andrew B, Sanders, Rogier W

“…Eliciting potent and broadly neutralizing antibodies (bnAbs) is a major goal in HIV-1 vaccine development. Here, we describe how germline-targeting immunogen…”
Get more information